This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Candelise, L. Articles by Brambilla, G. Search for Related Content PubMed PubMed Citation Articles by Candelise, L. Articles by Brambilla, G.

Stroke, Vol 13, 175-179, Copyright © 1982 by American Heart Association

ARTICLES

A randomized trial of aspirin and sulfinpyrazone in patients with TIA

L Candelise, G Landi, P Perrone, M Bracchi and G Brambilla

In a double-blind multicenter study, 124 patients with transient ischemic attacks were randomly allocated to one of two groups treated with aspirin (ASA) or sulfinpyrazone respectively. Patients were followed up to assess the relative efficacy of the two treatments in the prevention of the outcomes of stroke, myocardial infarction, vascular death, and worsening or no improvement of TIAs. No significant difference was observed between the two treatments at the end of the follow-up period. Statistical analysis revealed a significant interaction of sex, treatment, and occurrence of events. Analysis of the results according to sex showed that male patients treated with ASA had a highly significant benefit (p less than 0.001) with a 53% risk reduction for further events. In female patients, sulfinpyrazone showed a favorable trend which was not statistically significant.

This article has been cited by other articles:

				J. M. Holroyd-Leduc, M. K. Kapral, P. C. Austin, and J. V. Tu Sex Differences and Similarities in the Management and Outcome of Stroke Patients Stroke, August 1, 2000; 31(8): 1833 - 1837. [Abstract] [Full Text] [PDF]

				H. Iso, C. H. Hennekens, M. J. Stampfer, K. M. Rexrode, G. A. Colditz, F. E. Speizer, W. C. Willett, and J. E. Manson Prospective Study of Aspirin Use and Risk of Stroke in Women Stroke, September 1, 1999; 30(9): 1764 - 1771. [Abstract] [Full Text] [PDF]

				K. Kasischke, R. Huber, H. Li, M. Timmler, M. W. Riepe, and D. O. Carpenter Primary Hypoxic Tolerance and Chemical Preconditioning During Estrus Cycle in Mice • Editorial Comment Stroke, June 1, 1999; 30(6): 1256 - 1262. [Abstract] [Full Text] [PDF]

				J. He, P. K. Whelton, B. Vu, and M. J. Klag Aspirin and Risk of Hemorrhagic Stroke: A Meta-analysis of Randomized Controlled Trials JAMA, December 9, 1998; 280(22): 1930 - 1935. [Abstract] [Full Text] [PDF]

				H. Nishimura, H. Naritomi, Y. Iwamoto, H. Tachibana, and M. Sugita In Vivo Evaluation of Antiplatelet Agents in Gerbil Model of Carotid Artery Thrombosis Stroke, June 1, 1996; 27(6): 1099 - 1104. [Abstract] [Full Text]

				A. P. Sempere, J. Duarte, C. Cabezas, and L. E. Claveria Incidence of Transient Ischemic Attacks and Minor Ischemic Strokes in Segovia, Spain Stroke, April 1, 1996; 27(4): 667 - 671. [Abstract] [Full Text]

				Antiplatelet Trialists Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ, January 8, 1994; 308(6921): 81 - 106. [Abstract] [Full Text]

				A. Mingoli, R. T. Bailey JR., D. H. Kretchmar, J. A. Hagen, R. Santoscoy, W. J. Hunter, N. Gupta, R. C. Koe, and J. T. Sugimoto Effect of Low-Dose Aspirin on Platelet Adherence After Carotid Endarterectomy in Dogs Vascular and Endovascular Surgery, September 1, 1991; 25(7): 530 - 540. [Abstract] [PDF]